Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 25.2 | uM | 7905.011 | 0.8573 | 0.6876 | 0.9066 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 126 | uM | 7905.011 | 0.2771 | -0.5144 | 0.9066 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 629 | uM | 7905.011 | 0.0478 | -0.9301 | 0.9066 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.00161 | uM | 7906.011 | 0.5510 | -0.0659 | 0.7830 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.00805 | uM | 7906.011 | 1.1547 | 1.4034 | 0.7830 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.0403 | uM | 7906.011 | 1.0130 | 1.0333 | 0.7830 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.201 | uM | 7906.011 | 1.0207 | 1.0530 | 0.7830 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 1.01 | uM | 7906.011 | 0.9507 | 0.8750 | 0.7830 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 5.03 | uM | 7906.011 | 0.5449 | -0.0791 | 0.7830 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 25.2 | uM | 7906.011 | 0.8009 | 0.5062 | 0.7830 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 126 | uM | 7906.011 | 0.5884 | 0.0159 | 0.7830 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 629 | uM | 7906.011 | 0.1039 | -0.8890 | 0.7830 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.00161 | uM | 7907.011 | 1.1716 | 1.2374 | 1.4119 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.00805 | uM | 7907.011 | 0.8935 | 0.8467 | 1.4119 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.0403 | uM | 7907.011 | 1.1838 | 1.2538 | 1.4119 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.201 | uM | 7907.011 | 0.9474 | 0.9249 | 1.4119 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 1.01 | uM | 7907.011 | 1.1249 | 1.1738 | 1.4119 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 5.03 | uM | 7907.011 | 0.8020 | 0.7107 | 1.4119 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 25.2 | uM | 7907.011 | 0.8208 | 0.7389 | 1.4119 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 126 | uM | 7907.011 | 0.4607 | 0.1551 | 1.4119 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 629 | uM | 7907.011 | 0.0427 | -0.7858 | 1.4119 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.00161 | uM | 7909.075 | 1.0924 | 1.1188 | 1.5307 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.00806 | uM | 7909.075 | 0.9414 | 0.9226 | 1.5307 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.0403 | uM | 7909.075 | 1.1280 | 1.1637 | 1.5307 | |
MDA-MB-468 | TNBC | Basal A | Oxaliplatin | DNA cross-linker | DNA cross-linker | 0.201 | uM | 7909.075 | 0.9501 | 0.9342 | 1.5307 |